HOMEPRODUCTSSERVICESCOMPANYCONTACTFAQResearchDictionaryPharmaMobileSign Up FREE or Login

Philip A Poole-Wilson Selected Research

Nifedipine (Adalat)

3/2008Quality management of a large randomized double-blind multi-centre trial: the ACTION experience.
11/2007Diagnostic criteria and adjudication process both determine published event-rates: the ACTION trial experience.
8/2007Predictive value of local and core laboratory echocardiographic assessment of cardiac function in patients with chronic stable angina: The ACTION study.
8/2007Uric acid and other renal function parameters in patients with stable angina pectoris participating in the ACTION trial: impact of nifedipine GITS (gastro-intestinal therapeutic system) and relation to outcome.
7/2007Blood pressure reduction in stable angina by nifedipine was related to stroke and heart failure reduction but not to coronary interventions.
7/2007Resource utilization implications of treatment were able to be assessed from appropriately reported clinical trial data.
3/2007The development of heart failure in patients with stable angina pectoris.
1/2007Tracking coronary calcification and atherosclerotic lesions in patients with stable angina pectoris undergoing nifedipine therapy.
6/2006Incidence and outcome of atrial fibrillation in stable symptomatic coronary disease.
2/2006Safety of nifedipine GITS in stable angina: the ACTION trial.
For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research network!


Choose Username:
Email:
Password:
Verify Password:


Philip A Poole-Wilson Research Topics

Disease

51Heart Failure
04/2013 - 06/2002
8Myocardial Infarction
08/2007 - 09/2004
7Stroke (Strokes)
08/2007 - 02/2005
5Anemia
09/2011 - 07/2005
5Coronary Disease (Coronary Heart Disease)
03/2008 - 09/2004
5Angina Pectoris
03/2008 - 09/2004
4Coronary Artery Disease (Coronary Atherosclerosis)
01/2007 - 03/2005
3Heart Diseases (Heart Disease)
05/2008 - 07/2003
3Cardiovascular Diseases (Cardiovascular Disease)
02/2008 - 06/2002
2Cyanosis
03/2010 - 06/2006
2Transient Ischemic Attack
07/2007 - 03/2005
2Shock
06/2007 - 02/2005
2Cardiomyopathies (Cardiomyopathy)
03/2007 - 02/2007
2Body Weight (Weight, Body)
02/2007 - 10/2004
2Left Ventricular Dysfunction
03/2006 - 02/2005
2Hypotension (Low Blood Pressure)
02/2006 - 05/2003
1Necrosis
04/2013
1Liver Diseases (Liver Disease)
02/2012
1Disease Progression
01/2012
1Chronic Disease (Chronic Diseases)
09/2011
1Iron Overload
09/2011
1Iron-Deficiency Anemia (Anemia, Iron Deficiency)
09/2011
1Inflammation
09/2011
1Eisenmenger Complex (Eisenmenger's Syndrome)
03/2010
1Obstructive Sleep Apnea
06/2008
1Central Sleep Apnea (Central Sleep Apnea Syndrome)
06/2008
1Diabetic Coma
08/2007
1Diabetic Foot
08/2007
1Renal Insufficiency (Renal Failure)
08/2007
1Gangrene
08/2007
1Bradycardia
04/2007
1Chagas Cardiomyopathy
04/2007
1Unstable Angina
03/2007
1Atherosclerotic Plaque (Atheroma)
01/2007
1Cardiac Arrhythmias (Arrythmia)
11/2006
1Fibrosis (Cirrhosis)
11/2006
1Melanoma (Melanoma, Malignant)
02/2006
1Constipation
02/2006
1Asthenia
02/2006
1Neoplasms (Cancer)
02/2006
1Polyuria
02/2006
1Muscle Cramp (Cramp)
02/2006
1Erectile Dysfunction
02/2006
1Skin Neoplasms (Skin Cancer)
02/2006

Drug/Important Bio-Agent (IBA)

12Nifedipine (Adalat)FDA LinkGeneric
03/2008 - 09/2004
11carvedilol (Coreg)FDA LinkGeneric
08/2007 - 06/2002
10Metoprolol (Lopressor)FDA LinkGeneric
08/2007 - 06/2002
8Angiotensin-Converting Enzyme Inhibitors (ACE Inhibitors)IBA
01/2012 - 03/2003
8CreatinineIBA
09/2011 - 07/2003
5CalciumIBA
06/2011 - 05/2003
5Peptidyl-Dipeptidase A (Angiotensin Converting Enzyme)IBA
11/2009 - 03/2003
5Losartan (Cozaar)FDA LinkGeneric
11/2009 - 06/2002
5nebivololFDA Link
06/2009 - 02/2005
4DiureticsIBA
01/2012 - 05/2003
4IronIBA
09/2011 - 01/2008
4Hemoglobins (Hemoglobin)IBA
09/2011 - 07/2005
3Testosterone (Sustanon)FDA Link
09/2010 - 10/2006
3OxygenIBA
02/2007 - 05/2003
3Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
08/2005 - 07/2003
2Interleukin-6 (Interleukin 6)IBA
04/2013 - 07/2003
2Transferrin (beta 2 Transferrin)IBA
09/2011 - 12/2009
2Dehydroepiandrosterone (DHEA)IBA
09/2010 - 07/2005
2Angiotensin Receptor AntagonistsIBA
11/2009 - 09/2008
2Glucose (Dextrose)FDA LinkGeneric
08/2007 - 03/2007
2EnalaprilFDA LinkGeneric
04/2007 - 03/2003
1ErythropoietinFDA Link
04/2013
1Ursodeoxycholic Acid (Urso)FDA LinkGeneric
02/2012
1MicellesIBA
02/2012
1Digoxin (Digitek)FDA LinkGeneric
01/2012
1Sarcoplasmic Reticulum Calcium-Transporting ATPasesIBA
06/2011
1AndrogensIBA
09/2010
1C-Type Natriuretic Peptide (Peptide, C-Type Natriuretic)IBA
01/2010
1Hemoglobin AIBA
12/2009
1Ferritins (Ferritin)IBA
12/2009
1ferric carboxymaltoseIBA
12/2009
1Estradiol (Estrace)FDA LinkGeneric
05/2009
1Angiotensin IIIBA
09/2008
1fluvastatinFDA Link
02/2008
1Toll-Like Receptors (Toll-Like Receptor)IBA
02/2008
1Toll-Like Receptor 4IBA
02/2008
1saccharated ferric oxideFDA Link
01/2008
1Sucrose (Saccharose)IBA
01/2008
1Uric Acid (Urate)IBA
08/2007
1AngiotensinsIBA
07/2007
1Amiodarone (Amiodarona)FDA LinkGeneric
06/2007
1Spironolactone (Aldactone)FDA LinkGeneric
04/2007
1darbepoetin alfa (Aranesp)FDA Link
02/2007
1GadoliniumIBA
11/2006
1Dehydroepiandrosterone SulfateIBA
10/2006
1Insulin (Novolin)FDA Link
10/2006
1CholesterolIBA
09/2006
1Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA
09/2006
1Carbon DioxideIBA
06/2006
1Idiopathic pulmonary hypertensionIBA
06/2006
1N,N-dimethylarginine (asymmetric dimethylarginine)IBA
11/2005

Therapy/Procedure

1Fontan Procedure (Fontan Operation)
03/2010
1Implantable Defibrillators (Implantable Cardioverter-Defibrillator)
09/2009
1Continuous Positive Airway Pressure
06/2008
1Orthopedic Procedures
07/2007
1Stem Cell Transplantation
11/2005